Kentaro Nakata

Duke University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Masakiyo Sakaguchi

Okayama University

JAPAN

View details

Mikio Okazaki

Okayama University Hospital

JAPAN

View details

Kazuhiko Shien

Assistant Professor

Okayama University Hospital

JAPAN

View details

Akihiro Matsukawa

Okayama University

JAPAN

View details

Hiromasa Yamamoto

Assistant Professor

JAPAN

View details

shuta tomida

Associate Professor

Okayama University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kentaro Nakata

Research Interests

Explore related searches

Contact this professor

Articles (10)

Impact of simultaneous heart procurement on outcomes of donation after circulatory death lung transplantation

Functional Blockage of S100A8/A9 Ameliorates Ischemia–Reperfusion Injury in the Lung

Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast

Inhibiting S100A8/A9 attenuates airway obstruction in a mouse model of heterotopic tracheal transplantation

One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study

Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice

Staged surgery for empyema and lung gangrene caused by pseudoaneurysm after radiofrequency ablation

YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers

Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer

Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic <i>BRAF</i> Mutation

Collaborators (6)

Masakiyo Sakaguchi

Mikio Okazaki

Kazuhiko Shien

Akihiro Matsukawa

Hiromasa Yamamoto

shuta tomida

Make your next move.